.On the heels of an FDA being rejected for its primary competing Novo Nordisk, Eli Lilly is picking ...
.Merely a couple of months after application the 1st individual in a phase 2 test for newly detected...
.Eli Lilly's hunt for obesity aim ats has led it to the dark genome. The Big Pharma has crafted a de...
.Toolbox Biosciences is carrying on up. The cell therapy company has added $325 million in ammunitio...
.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...
.Aelis Farma's hopes of safeguarding a simple, good choice on a $100 million option payment have fai...
.ProKidney has ceased one of a pair of phase 3 trials for its cell treatment for kidney condition af...
.Vaxcyte introduced what professionals called "magnificent" period 1/2 data for its own 31-valent pn...
.Recursion has discovered by means of a very early test of its own tech-enabled strategy to medicati...
.Call it a situation of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning scie...